Clinical trials
Recruiting Phase 1 Primary Myelofibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 26 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Incyte Corporation | 3 |
| University of Utah | 2 |
| Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company | 1 |
| Aspera Biomedicines, Inc. | 1 |
| Cellenkos, Inc. | 1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
| City of Hope Medical Center | 1 |
| Damora Therapeutics | 1 |
| Eilean Therapeutics AU Pty Ltd | 1 |
| Epigenetix, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Myelofibrosis | 26 |
| Myeloproliferative Disorders | 9 |
| Myelodysplastic Syndromes | 7 |
| Thrombocythemia, Essential | 7 |
| Leukemia, Myeloid, Acute | 6 |
| Leukemia, Myelomonocytic, Chronic | 5 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 4 |
| Polycythemia Vera | 4 |
| Hematologic Neoplasms | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.